Medical treatment of endometriosis
Review
OA: closed
CC0
⤵ 39 in-corpus citations
AI-generated summary
This paper reviews the medical treatment options for endometriosis, discussing hormonal and non-hormonal therapies for managing the condition.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Wayne State University/Hutzel Hospital, Detroit, Michigan Correspondence: Kamran S. Moghissi, MD, Professor, Department of Obstetrics & Gynecology, Division of Reproductive Endocrinology & Infertility, Wayne State University/Hutzel Hospital, 4707 St. Antoine Boulevard, Detroit, MI 48201.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (26)
- Administration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial via openalex
- Comparison of cyproterone acetate and danazol in the treatment of pelvic pain associated with endometriosis via openalex
- Comparison of different treatment modalities of endometriosis in infertile women via openalex
- Comparison of different treatment modalities of endometriosis in infertile women via openalex
- Danazol. A synthetic steroid with diverse biologic effects via openalex
- Depot medroxyprogesterone acetate versus an oral contraceptive combined with very-low-dose danazol for long-term treatment of pelvic pain associated with endometriosis via openalex
- Endometriosis and the estrogen threshold theory. Relation to surgical and medical treatment via openalex
- Evaluation of oral medroxyprogesterone acetate in the treatment of endometriosis via openalex
- Gestrinone versus a gonadotropin-releasing hormone agonist for the treatment of pelvic pain associated with endometriosis: a multicenter, randomized, double-blind study. Gestrinone Italian Study Group via openalex
- Gonadotropin-releasing hormone agonist plus estrogen-progestin "add-back" therapy for endometriosis-related pelvic pain via openalex
- Human issues and medical economics of endometriosis. Three- vs. six-month GnRH-agonist therapy via openalex
- Immunologic aspects of endometriosis via openalex
- Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double-blind study. Lupron Study Group via openalex
- Management of endometriosis in the infertile patient via openalex
- Management of endometriosis with oral medroxyprogesterone acetate via openalex
- Megestrol acetate for treatment of endometriosis via openalex
- Progestins for symptomatic endometriosis: a critical analysis of the evidence via openalex
- Retreatment with nafarelin for recurrent endometriosis symptoms: efficacy, safety, and bone mineral density via openalex
- The effect of add-back treatment with tibolone (Livial) on patients treated with the gonadotropin-releasing hormone agonist triptorelin (Decapeptyl) via openalex
- Zoladex (goserelin acetate implant) in the treatment of endometriosis: a randomized comparison with danazol. The Zoladex Endometriosis Study Group via openalex
- W2228635764 via openalex
- W2093512443 via openalex
- W201040832 via openalex
- W2123876576 via openalex
- W1618997004 via openalex
- W164119867 via openalex
Cited by (41)
- Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery 2021
- On-label and off-label drug use in the treatment of endometriosis 2015
- LH (Trp8Arg/Ile15Thr), LHR (insLQ) and FSHR (Asn680Ser) polymorphisms genotypic prevalence in women with endometriosis and infertility 2015
- On-label and off-label drug use in the treatment of endometriosis 2015
- Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery 2013
- TO DETERMINE THE USE OF AN LNG-IUS FOR CONSERVATIVE MANAGEMENT IN WOMEN WITH SYMPTOMATIC MILD TO MODERATE ENDOMETRIOSIS 2013
- Levonorgestrel-releasing intrauterine device for symptomatic endometriosis following surgery 2013
- Changes in glandular and stromal estrogen and progesterone receptor isoform expression in eutopic and ectopic endometrium following treatment with the levonorgestrel-releasing intrauterine system 2011
- The non-human primate model of endometriosis: research and implications for fecundity 2009
- Decidualization attenuates the contractility of eutopic and ectopic endometrial stromal cells: implications for hormone therapy of endometriosis 2009
- Benign gynecologic conditions 2008
- Options for hormone therapy in women who have had a hysterectomy 2007
- Cytokines regulate matrix metalloproteinases in human uterine endometrial fibroblast cells through a mechanism that does not involve increases in extracellular matrix metalloproteinase inducer 2006
- Tratamiento médico de la endometriosis (excluyendo la adenomiosis) 2006
- Selective cyclo-oxygenase-2 inhibition induces regression of autologous endometrial grafts by down-regulation of vascular endothelial growth factor-mediated angiogenesis and stimulation of caspase-3-dependent apoptosis 2006
- Oral contraceptives for endometriosis-associated pain 2006
- Selective cyclo-oxygenase-2 inhibition induces regression of autologous endometrial grafts by down-regulation of vascular endothelial growth factor-mediated angiogenesis and stimulation of caspase-3-dependent apoptosis 2006
- Role of immunologic and inflammatory factors in the development of endometriosis: indications for treatment strategies 2005
- Traitement médicamenteux de l'endométriose (adénomyose exclue) 2005
- Traitement médicamenteux de l'endométriose (adénomyose exclue) 2005
- Role of immunologic and inflammatory factors in the development of endometriosis: indications for treatment strategies 2005
- Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery 2005
- Sistema intra-uterino liberador de levonorgestrel no controle da dor pelvica em mulheres com endometriose 2005
- The relevancy of the matrix metalloproteinase system to the pathophysiology of endometriosis 2005
- The Efficacy, Side-Effects and Continuation Rates in Women With Symptomatic Endometriosis Undergoing Treatment With an Intra-uterine Administered Progestogen (Levonorgestrel): A 3 Year Follow-up 2005
- The efficacy, side-effects and continuation rates in women with symptomatic endometriosis undergoing treatment with an intra-uterine administered progestogen (levonorgestrel): a 3 year follow-up 2004
- Presence of endometrial epithelial cells in the peritoneal cavity and the mesothelial inflammatory response 2003
- The evaluation of the effectiveness of an intrauterine-administered progestogen (levonorgestrel) in the symptomatic treatment of endometriosis and in the staging of the disease 2003
- Endometriosis and its treatment with danazol or lupron in relation to ovarian cancer 2003
- Medical management of endometriosis: novel targets and approaches towards the development of future treatment regimes 2003
- Endometriosis 2003
- Endometriosis: treatment strategies 2003
- Comprehensive preventive health care in female-factor infertility: issues, problems and proposals 2002
- Endometriosis: current concepts and therapy 2002
- Results of assisted reproductive technologies in patients with endometriosis 2002
- Treatment of endometriosis 2001
- Endometriosis ileal. A propósito de un caso 2001
- Treating endometriosis as an autoimmune disease 2001
- Endometriosis-associated infertility 2000
- Medical management of endometriosis and infertility 2000
- 10.1016/s0186-0216(08)88002-0 2000
Source provenance
- europepmc
- last seen: 2026-10-09T06:09:53.026058+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T20:59:07.345995+00:00
License: CC0
· commercial use OK